日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5.

基于 AAV8 的基因替代疗法治疗遗传性痉挛性截瘫 5 型

Wiora Linus, Yuan Qinggong, Hook Sebastian, Kraft Melanie, Björkhem Ingemar, Ott Michael, Hauser Stefan, Schöls Ludger

A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis.

法尼醇 X 受体 T296I 变体破坏配体诱导的 FXR 激活,从而破坏进行性家族性肝内胆汁淤积症中的胆汁酸转运。

Behrendt Annika, Bastianelli Alex, Stindt Jan, Pfister Eva-Doreen, Sgodda Malte, Cantz Tobias, Hook Sebastian, Gopalswamy Mohanraj, Grau Kathrin, Brands Stefanie, Dröge Carola, Stalke Amelie, Bonus Michele, Franke Sabine, Baumann Ulrich, Keitel Verena, Gohlke Holger